Kidney Cancer Features
80% of lung cancer deaths linked to smoking, researchers say.
Latest Kidney Cancer News
Nivolumab is cleared for treating patients with metastatic RCC whose disease advanced despite prior treatment with anti-angiogenic therapy.
For patients with diabetes, poor glycemic control linked to higher risk of post-operative progression.
Specific alterations seen in type 1 and type 2 carcinomas; type 2 consists of at least 3 subtypes.
Dialysis, organ transplant may increase odds for certain types of cancer.
High-heat cooking methods implicated in new study.
On-treatment neutropenia and hypertension are independently associated with decreased mortality risk.
Researchers report a survival advantage over observation among elderly patients with localized tumors.
Case report describes 84-year-old male patient with myositis after nivolumab treatment.
Higher stroke risk found in older kidney cancer patients taking the drugs.
The model incorporates 2 newly identified independent mortality risk factors in patients requiring second-line targeted therapy.
Active surveillance equal to partial nephrectomy for renal function preservation.
In separate studies, nivolumab prolonged overall survival and cabozantinib improved progression-free survival compared with everolimus.
Trend mirrors move to targeted therapy era.
Higher risk for clear cell, papillary renal cell carcinoma, but not chromophobe histology.
Kidney Cancer Videos
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)